MedSurge Advances Introduces the clearCONCEPT(TM) Acne Treatment Process
Posted on: Tuesday, 20 June 2006, 09:00 CDT
MedSurge Advances, the leading aesthetic medicine services provider for physicians, today announced the availability of the clearCONCEPT(TM) Acne Treatment Process, a new combination therapy that delivers superior clinical outcomes without the need for antibiotics in most cases.
Developed by MedSurge Advances and a team of nationally recognized physicians, the clearCONCEPT Acne Treatment Process combines the latest light-based technologies, microdermabrasion and physician-only topical treatments to treat acne and its scars -- aggressively, effectively and safely.
"This therapy is unique in that it combines treatment modalities to deliver clearer skin without the need for antibiotics for most patients," said Dr. Brian Zelickson, a member of the clearCONCEPT development team and a board-certified dermatologist who practices at Cosmetic Care Center in Minneapolis, Minn.
The clearCONCEPT Acne Treatment Process treats clogged pores through exfoliation and cleansing, reduces oil production with laser therapy, eliminates acne-causing bacteria with light therapy and topical treatments, and reduces scarring with microdermabrasion and other procedures. Using proprietary algorithms and protocols, a clearCONCEPT physician assesses each patient and recommends a customized treatment plan to deliver optimal results.
The clearCONCEPT therapy is currently offered by physicians in 14 states -- including Arizona, California, Florida, Maryland, Massachusetts, Minnesota, New Jersey, New York, North Carolina, Ohio, Oregon, Texas, Utah, and Virginia - and is expanding nationally. The clearCONCEPT Acne Treatment Process is generally available directly through family practitioners and other primary care physicians.
"Many physicians have been slow to incorporate light and laser therapies into their practices. This creates an opportunity for other physicians to step in and offer these much-needed services," said Paul Herchman, CEO of MedSurge Advances. "The clearCONCEPT Acne Treatment Process makes it relatively simple for primary care physicians to offer a comprehensive acne solution to their patients."
Added Herchman: "Because we are able to offer this therapy through family practitioners, patients typically don't have to wait six weeks to receive treatment - which is often the case when scheduling an appointment with a specialist."
About MedSurge Advances
Based in Dallas, MedSurge Advances is the nation's largest independent provider of aesthetic medicine products and services to physicians. MedSurge Advances helps physicians across the United States build and manage their practices in aesthetic medicine, one of the fastest-growing healthcare segments. Since its founding in 2002, MedSurge Advances has provided technology and business resources for hundreds of physicians who have started stand-alone businesses or added aesthetic procedures to their existing practices.
Source: Business Wire
Related Articles
- Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation
- Ipsen Announces the Filing of Decapeptyl(R) 6-Month Formulation for the Treatment of Locally Advanced or Metastatic Prostate Cancer in Europe
- Cancer Treatment Specialists Highlight Clinical Benefits, Expanded Range of TomoTherapy's Advanced Radiation Therapy Technology
- Leading Italian Hospital Chooses TomoTherapy To Advance Radiation Therapy Program
- Elekta Selected to Supply Advanced Radiation Therapy Capability to Greece's Largest Private Hospital
- Elekta Selected to Supply the Royal Marsden Hospital in London, UK, With Additional Advanced Radiation Therapy Systems
- Medtronic Unveils New Advanced Diabetes Therapy Management Software at 67th Annual American Diabetes Association Meeting
- CollaGenex Pharmaceuticals Announces Positive Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Acne
- CollaGenex Pharmaceuticals Initiates Phase 2 Clinical Trial to Evaluate Incyclinide (COL-3) for the Treatment of Acne
- SurModics Enters into Agreement With University of Arizona to Develop Advanced Medical Therapies
User Comments (0)

RSS Feeds